Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

It is unethical for the United States to send hydroxychloroquine to Brazil

Charles E. Binkley, MD
Meds
June 7, 2020
Share
Tweet
Share

Much controversy surrounds whether or not hydroxychloroquine is effective in preventing or treating infection with COVID-19. While much of the data so far suggests that hydroxychloroquine is not effective at treating COVID-19, and perhaps that it might even be harmful, multiple clinical trials focusing both on prevention and treatment are ongoing. The controversy around hydroxychloroquine led the FDA to issue a statement advising against the use of hydroxychloroquine for COVID-19 outside of the hospital setting or a clinical trial.

In a joint statement between the United States of America and the Federative Republic of Brazil issued on May 31, 2020, the two countries announced that the United States government had delivered two million doses of hydroxychloroquine to the people of Brazil. The statement designates that the drug is to be used both for prophylaxis against COVID-19 among health care workers and treatment of those already infected. It also announces a joint United States-Brazilian research effort to evaluate the safety and efficacy of hydroxychloroquine for the prevention and treatment of COVID-19. Along with hydroxychloroquine, the United States also sent 1,000 ventilators to Brazil.

The ethical issue with sending hydroxychloroquine to Brazil is that the medication’s benefit in preventing or treating COVID-19, and its potential for harm, are unknown and unproven. A very basic requirement of both the World Health Organization (WHO) and the Food and Drug Administration (FDA) is that medications donated for humanitarian aid be safe and effective. The donation of hydroxychloroquine to Brazil directly violates the FDA’s policy, as well as the WHO’s policy, on medicine donations. Beyond that, the donation is contrary to the moral foundations on which medicine is based: to do good and avoid harm. Providing a medication whose safety and efficacy is unproven to vulnerable populations is not what anyone should call humanitarian. Of further concern is how the medication will be distributed and used in Brazil where, according to one publication, the country’s COVID-19 response is “caught between denialism and technocratic hubris.”

Regardless of how they estimate their authority, presidents cannot prescribe medications; only doctors and advanced practice clinicians can do this. The reason is based not only on training and education, but also the recognition that medications can be used both for benefit and for harm. The privilege to prescribe entails a moral obligation that medication be used for the good of the patient and not for their harm. Take, for instance, the decision of President Trump’s physician, Dr. Sean Conley, to prescribe the president hydroxychloroquine. Notwithstanding the fact that Dr. Conley and the President “concluded the potential benefit outweighed the relative risks,” the decision is ethically ambiguous. Patients often request medications and interventions that physicians know to be nonbeneficial, and even potentially harmful. Saying “no” can be one of the most difficult parts of the job. It is not just our professional judgment, but also our moral obligation.

Based on the joint statement from the United States and Brazil, one may argue that the medication is being given to Brazil not as humanitarian aid, but as part of a research study. Had the purpose been to enlist international participation in a study of hydroxychloroquine, a far more ethical solution would have been to encourage participation in an already existing study.  Doing so would assure Institutional Review Board (IRB) oversight, a robust informed-decision-making process, standardized criteria for participation, safety monitoring, and all the other elements on which scientifically grounded, ethically sound clinical research is carried out. Furthermore, the medical community is unlikely to trust any conclusions that are not the result of a well-designed and scientifically respected study.

The donation of hydroxychloroquine, in contrast to the accompanying donation of 1,000 ventilators, is unethical as either humanitarian aid or as a “research study.” The United States has a moral responsibility for any human harm that results. We cannot simply send medications off to potentially vulnerable populations without regard for the lives that could be negatively affected. It is not enough to intend to do good and avoid harm; we must ensure it.

Charles E. Binkley is a bioethicist and general surgeon.

Image credit: Shutterstock.com

Prev

Why whole person care is needed for better population health management

June 7, 2020 Kevin 0
…
Next

We need more black cops. We need more black physicians.

June 7, 2020 Kevin 7
…

Tagged as: COVID, Infectious Disease, Medications

Post navigation

< Previous Post
Why whole person care is needed for better population health management
Next Post >
We need more black cops. We need more black physicians.

ADVERTISEMENT

More by Charles E. Binkley, MD

  • The failure of the U.S. government’s physicians to do good, avoid harm, and tell the truth

    Charles E. Binkley, MD
  • Unethical policy: Resuming federal lethal injections during a global pandemic

    Charles E. Binkley, MD
  • Mike Pence and the Mayo Clinic’s moral failure

    Charles E. Binkley, MD

Related Posts

  • We are on the brink of a crisis-level physician shortage in the United States

    Jamie Katuna
  • What health reform can learn from United Airlines

    Brian C. Joondeph, MD
  • Working parents are key members of the United States workforce

    Inna Husain, MD and Meeta Shah, MD
  • Why is health care so expensive in the United States?

    Scott Treutlein, MD
  • Governor Abbott’s decree: medically harmful, scientifically unfounded, and unethical

    Michael Morse, MD and Christian Moser, MD
  • Unethical policy: Resuming federal lethal injections during a global pandemic

    Charles E. Binkley, MD

More in Meds

  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • The food-drug interaction risks your doctor may be missing

    Frank Jumbe
  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How community paramedicine impacts Indigenous elders

      Noah Weinberg | Conditions
    • Why Canada is losing its skilled immigrant doctors

      Olumuyiwa Bamgbade, MD | Physician
    • How to speak the language of leadership to improve doctor wellness [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How medical culture hides burnout in plain sight

      Marco Benítez | Conditions
  • Recent Posts

    • Why Canada is losing its skilled immigrant doctors

      Olumuyiwa Bamgbade, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Would The Pitts’ Dr. Robby Robinavitch welcome a new colleague? Yes. Especially if their initials were AI.

      Gabe Jones, MBA | Tech
    • Why medicine must stop worshipping burnout and start valuing humanity

      Sarah White, APRN | Conditions
    • Why screening for diseases you might have can backfire

      Andy Lazris, MD and Alan Roth, DO | Physician
    • How organizational culture drives top talent away [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How community paramedicine impacts Indigenous elders

      Noah Weinberg | Conditions
    • Why Canada is losing its skilled immigrant doctors

      Olumuyiwa Bamgbade, MD | Physician
    • How to speak the language of leadership to improve doctor wellness [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How medical culture hides burnout in plain sight

      Marco Benítez | Conditions
  • Recent Posts

    • Why Canada is losing its skilled immigrant doctors

      Olumuyiwa Bamgbade, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Would The Pitts’ Dr. Robby Robinavitch welcome a new colleague? Yes. Especially if their initials were AI.

      Gabe Jones, MBA | Tech
    • Why medicine must stop worshipping burnout and start valuing humanity

      Sarah White, APRN | Conditions
    • Why screening for diseases you might have can backfire

      Andy Lazris, MD and Alan Roth, DO | Physician
    • How organizational culture drives top talent away [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

It is unethical for the United States to send hydroxychloroquine to Brazil
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...